Versant Venture Management as of June 30, 2023
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Repare Therapeutics Common Stock (RPTX) | 33.2 | $28M | 2.6M | 10.58 | |
| CRISPR Therapeutics Common Shares (CRSP) | 33.2 | $28M | 499k | 56.14 | |
| Adverum Biotechnologies Common Stock | 9.6 | $8.1M | 5.1M | 1.59 | |
| Gritstone Oncology Common Stock (GRTS) | 8.2 | $6.9M | 3.6M | 1.95 | |
| CymaBay Therapeutics Common Stock | 7.1 | $6.0M | 544k | 10.95 | |
| Passage Bio Common Stock (PASG) | 5.5 | $4.7M | 5.0M | 0.94 | |
| Aligos Therapeutics Common Stock (ALGS) | 2.7 | $2.3M | 2.3M | 0.97 | |
| Minerva Surgical Common Stock | 0.5 | $429k | 1.7M | 0.26 |
